This is a community-generated profile. If you would like to claim it, please .
DiscoverStartupsCornerstone PharmaceuticalsCornerstone Pharmaceuticals Funding Rounds, Valuation & Investors
Cornerstone Pharmaceuticals Funding
$19.2M
44 rounds
Cornerstone Pharmaceuticals is active in the following markets / industries: biotechnology. The company has secured funding across 4 rounds, totaling in an amount of $19.2M. Their most recent funding was raised on March 7, 2014.
Funding Rounds
U
$3300000U
$3800000B
$6100000U
$6000000Investors of Cornerstone Pharmaceuticals
Bill Garner
Founder or co-founder of four drug development companies; an MD with additional training in pathology at Columbia and a Harvard MPH.